Targeting Hypoxia, HIF-1, and Tumor Glucose Metabolism to Improve Radiotherapy Efficacy : Reinventing Cancer Cell MetabolismMEIJER, Tineke W. H; KAANDERS, Johannes H. A. M; SPAN, Paul N et al.Clinical cancer research (Print). 2012, Vol 18, Num 20, pp 5585-5594, issn 1078-0432, 10 p.Article

Improving chemoradiation efficacy by PI3-K/AKT inhibitionSTEGEMAN, Hanneke; SPAN, Paul N; KAANDERS, Johannes H. A. M et al.Cancer treatment reviews. 2014, Vol 40, Num 10, pp 1182-1191, issn 0305-7372, 10 p.Article

Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: Spatial distribution and prognostic value of GLUT1 and MCT4MEIJER, Tineke W. H; SCHUURBIERS, Olga C. J; BUSSINK, Johan et al.Lung cancer. 2012, Vol 76, Num 3, pp 316-323, issn 0169-5002, 8 p.Article

Hypoxic Regulation and Prognostic Value of LAMP3 Expression in Breast CancerNAGELKERKE, Anika; MUJCIC, Hilda; BUSSINK, Johan et al.Cancer. 2011, Vol 117, Num 16, pp 3670-3681, issn 0008-543X, 12 p.Article

Postoperative serum proteomic profiles may predict recurrence-free survival in high-risk primary breast cancerGAST, Marie-Christine W; ZAPATKA, Marc; VAN TINTEREN, Harm et al.Journal of cancer research and clinical oncology. 2011, Vol 137, Num 12, pp 1773-1783, issn 0171-5216, 11 p.Article

Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?SPAN, Paul N; TJAN-HEIJNEN, Vivianne C. G; HEUVEL, Joop J. T. M et al.Clinical chemistry (Baltimore, Md.). 2006, Vol 52, Num 9, pp 1693-1700, issn 0009-9147, 8 p.Article

TRPM7 Is Required for Breast Tumor Cell MetastasisMIDDELBEEK, Jeroen; KUIPERS, Arthur J; SWEEP, Fred C. G. J et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 16, pp 4250-4261, issn 0008-5472, 12 p.Article

The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapyYI ZHANG; SIEUWERTS, Anieta M; TUBBS, Raymond R et al.Breast cancer research and treatment. 2009, Vol 116, Num 2, pp 303-309, issn 0167-6806, 7 p.Article

Complex of urokinase-type plasminogen activator with its type 1 inhibitor predicts poor outcome in 576 patients with lymph node-negative breast carcinomaMANDERS, Peggy; TJAN-HEIJNEN, Vivianne C. G; SPAN, Paul N et al.Cancer. 2004, Vol 101, Num 3, pp 486-494, issn 0008-543X, 9 p.Article

Development of an ELISA for measurement of BCARI protein in human breast cancer tissueGREBENCHTCHIKOV, Nicolai; BRINKMAN, Arend; DORSSERS, Lambert C. J et al.Clinical chemistry (Baltimore, Md.). 2004, Vol 50, Num 8, pp 1356-1363, issn 0009-9147, 8 p.Article

Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP-3 is associated with adjuvant endocrine therapy success. CommentarySPAN, Paul N; LINDBERG, Raija L. P; MANDERS, Peggy et al.Journal of pathology. 2004, Vol 202, Num 4, pp 391-394, issn 0022-3417, 12 p.Article

Molecular Beacon reverse transcription-PCR of human chorionic gonadotropin-ss-3, -5, and -8 mrnas has prognostic value in breast cancerSPAN, Paul N; MANDERS, Peggy; HEUVEL, Joop J. T. M et al.Clinical chemistry (Baltimore, Md.). 2003, Vol 49, Num 7, pp 1074-1080, issn 0009-9147, 7 p.Article

Comparative Proteome Analysis Revealing an 11-Protein Signature for Aggressive Triple-Negative Breast CancerNING QING LIU; STINGL, Christoph; MANGIA, Anita et al.Journal of the National Cancer Institute. 2014, Vol 106, Num 2, issn 0027-8874, 1.1-1.10Article

Quantification of Patient-Specific Assay Interference in Different Formats of Enzyme-Linked Immunoassays for Therapeutic Monoclonal AntibodiesGREBENCHTCHIKOV, Nicolai; GEURTS-MOESPOT, Anneke J; HEIJMEN, Linda et al.Therapeutic drug monitoring. 2014, Vol 36, Num 6, pp 765-770, issn 0163-4356, 6 p.Article

Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trialNIJKAMP, Monique M; SPAN, Paul N; TERHAARD, Christiaan H. J et al.European journal of cancer (1990). 2013, Vol 49, Num 15, pp 3202-3209, issn 0959-8049, 8 p.Article

Cathepsins B, L and cystatin C in cyst fluid of ovarian tumorsKOLWIJCK, Eva; MASSUGER, Leon F. A. G; THOMAS, Chris M. G et al.Journal of cancer research and clinical oncology. 2010, Vol 136, Num 5, pp 771-778, issn 0171-5216, 8 p.Article

Predictive impact of urokinase-type plasminogen activator: Plasminogen activator inhibitor type-1 complex on the efficacy of adjuvant systemic therapy in primary breast cancerMANDERS, Peggy; TJAN-HEIJNEN, Vivianne C. G; SPAN, Paul N et al.Cancer research (Baltimore). 2004, Vol 64, Num 2, pp 659-664, issn 0008-5472, 6 p.Article

The complex between urokinase-type plasminogen activator (uPA) and its type-I inhibitor (PAI-I) independently predicts response to first-line endocrine therapy in advanced breast cancerMANDERS, Peggy; G.TJAN-HEIJNEN, Vivianne C; SPAN, Paul N et al.Thrombosis and haemostasis. 2004, Vol 91, Num 3, pp 514-521, issn 0340-6245, 8 p.Conference Paper

Effects of PhD examination stress on allopregnanolone and cortisol plasma levels and peripheral benzodiazepine receptor densityFORTUYN, Hal A; VAN BROEKHOVEN, Frank; SPAN, Paul N et al.Psychoneuroendocrinology. 2004, Vol 29, Num 10, pp 1341-1344, issn 0306-4530, 4 p.Article

Short-term glucosamine infusion does not affect insulin sensitivity in humansPOUWELS, Marie-Jose J; JACOBS, Judith R; SPAN, Paul N et al.The Journal of clinical endocrinology and metabolism. 2001, Vol 86, Num 5, pp 2099-2103, issn 0021-972XArticle

Expression of the BRCA1 complex member BRE predicts disease free survival in breast cancerNOORDERMEER, Sylvie M; WENNEMERS, Marloes; BERGEVOET, Saskia M et al.Breast cancer research and treatment. 2012, Vol 135, Num 1, pp 125-133, issn 0167-6806, 9 p.Article

Magnetic Resonance Lymphography Findings in Patients With Biochemical Recurrence After Prostatectomy and the Relation With the Stephenson NomogramMEIJER, Hanneke J. M; DEBATS, Oscar A; ROACH, Mack et al.International journal of radiation oncology, biology, physics. 2012, Vol 84, Num 5, pp 1186-1191, issn 0360-3016, 6 p.Article

Accelerated Radiotherapy With Carbogen and Nicotinamide for Laryngeal Cancer: Results of a Phase III Randomized TrialJANSSENS, Geert O; RADEMAKERS, Saskia E; HOOGSTEEN, Ilse J et al.Journal of clinical oncology. 2012, Vol 30, Num 15, pp 1777-1783, issn 0732-183X, 7 p.Conference Paper

Rho GDP dissociation inhibitor α expression correlates with the outcome of CMF treatment in invasive ductal breast cancerRONNEBURG, Henrike; SPAN, Paul N; KANTELHARDT, Eva et al.International journal of oncology. 2010, Vol 36, Num 2, pp 379-386, issn 1019-6439, 8 p.Article

The balance between extracellular cathepsins and cystatin C is of importance for ovarian cancerKOLWIJCK, Eva; KOS, Janko; OBERMAJER, Natasja et al.European journal of clinical investigation. 2010, Vol 40, Num 7, pp 591-599, issn 0014-2972, 9 p.Article